These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 15592526

  • 21. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6479-88. PubMed ID: 16166423
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP, Swinler SE, Lutterbaugh JD, Massagué J, Thiagalingam S, Kinzler KW, Vogelstein B, Willson JK, Markowitz S.
    Cancer Res; 2001 Jan 01; 61(1):256-60. PubMed ID: 11196171
    [Abstract] [Full Text] [Related]

  • 23. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
    Xiangming C, Natsugoe S, Takao S, Hokita S, Ishigami S, Tanabe G, Baba M, Kuroshima K, Aikou T.
    Clin Cancer Res; 2001 Feb 01; 7(2):277-82. PubMed ID: 11234879
    [Abstract] [Full Text] [Related]

  • 24. Smad4 deficiency in cervical carcinoma cells.
    Baldus SE, Schwarz E, Lohrey C, Zapatka M, Landsberg S, Hahn SA, Schmidt D, Dienes HP, Schmiegel WH, Schwarte-Waldhoff I.
    Oncogene; 2005 Jan 27; 24(5):810-9. PubMed ID: 15531914
    [Abstract] [Full Text] [Related]

  • 25. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
    Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE.
    Cancer Res; 1998 Dec 01; 58(23):5329-32. PubMed ID: 9850059
    [Abstract] [Full Text] [Related]

  • 26. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
    Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H.
    Cancer; 2002 Aug 15; 95(4):737-43. PubMed ID: 12209716
    [Abstract] [Full Text] [Related]

  • 27. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
    Schwarte-Waldhoff I, Klein S, Blass-Kampmann S, Hintelmann A, Eilert C, Dreschers S, Kalthoff H, Hahn SA, Schmiegel W.
    Oncogene; 1999 May 20; 18(20):3152-8. PubMed ID: 10340387
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
    Ijichi H, Ikenoue T, Kato N, Mitsuno Y, Togo G, Kato J, Kanai F, Shiratori Y, Omata M.
    Biochem Biophys Res Commun; 2001 Nov 30; 289(2):350-7. PubMed ID: 11716479
    [Abstract] [Full Text] [Related]

  • 33. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9719-23. PubMed ID: 11481457
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, Kalthoff H, Fändrich F, Ungefroren H.
    Oncogene; 2007 Jul 19; 26(33):4850-62. PubMed ID: 17297450
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
    Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Xu ZD, Liu LM.
    Carcinogenesis; 2009 Sep 19; 30(9):1497-506. PubMed ID: 19546161
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.